FOSTER CITY, Calif.--The value of the bioinformatics market could exceed $1.5 billion by 2005, but its compound annual growth rate is expected to decline as segments of the market become saturated, according to a new study, "Bioinformatics, a Strategic Business Analysis," published by Front Line Strategic Management Consulting here. The study's definition of the bioinformatics market includes providers of data, enterprise systems, and analytical software. Front Line said it expects the compound annual growth rate in bioinformatics to decline between 2001 and 2005 as customer needs are addressed.
The report stated that demand for genomics data has outpaced supply until now. But it asserted that "new data suppliers will emerge in this market offering access to their proprietary data for a fee, charging a premium price for early access to data that is not available from other sources."